You are here

Profile

Dr. Philip Halloran

Affiliation

University of Alberta

Academy or College

Academy of Science

Year Elected

2007

Areas of Interest

transplantation, immunology, genomics, disease phenotyping, microarrays

Long Citation
Dr. Halloran is an international leader and pioneer in organ transplantation. His seminal contributions include: delineating the role of interferon-y in injury and rejection and. its effect on MHC l and II; describing mechanisms of T cell mediated and antibody mediated rejection; describing the effects of somatic cell senescence on transplant performance; and developing diagnostic systems for transplantation. Recently, he has annotated the transcriptome of rejecting kidney to significantly advance a mechanistic understanding of allograft rejection. Dr. Halloran has significantly advanced clinical transplant medicine through the study and optimization of immunosuppressive therapy resulting in improved outcomes for transplant patients worldwide. Dr. Halloran is founding Editor of the American Journal of Transplantation, the leading journal in transplantation, and was recently named an Officer of the Order of Canada.

Short Citation
Dr. Halloran is an international leader and pioneer in organ transplantation. His has made seminal contributions that have significantly advanced clinical transplant medicine through the study and optimization of immunosuppressive therapy resulting in improved outcomes for transplant patients worldwide. Dr. Halloran is founding Editor of the American Journal of Transplantation and an Officer of the Order of Canada.